R
Resonancepharma
Resonance Pharma develops innovative diagnostics and medicines by focusing on the role of specific lipid metabolites in disease biology. The company utilizes a precision medicine toolset to identify and target individual secreted phospholipase A2 (sPLA 2) isoforms with diagnostic-drug pairs. This approach aims to deliver stratified therapeutics for severe conditions such as cancer and sepsis by blocking inflammatory cascades at their origin.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Resonance Pharma develops innovative diagnostics and medicines by focusing on the role of specific lipid metabolites in disease biology. The company utilizes a precision medicine toolset to identify and target individual secreted phospholipase A2 (sPLA 2) isoforms with diagnostic-drug pairs. This approach aims to deliver stratified therapeutics for severe conditions such as cancer and sepsis by blocking inflammatory cascades at their origin.